Nanjing, China

Changjun Lin


 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Changjun Lin in Pharmaceutical Chemistry

Introduction

Changjun Lin, an accomplished inventor based in Nanjing, China, has made significant contributions to the field of pharmaceutical chemistry. With a patent to his name, Lin's work demonstrates a relentless pursuit of innovation aimed at addressing pressing health challenges.

Latest Patents

Lin's notable patent focuses on a garcinia derivative, detailed as Formula (I). This groundbreaking invention is not only a preparation method but also highlights the medicinal use of this garcinia derivative. It pertains to a structurally simplified analogue of the gambogic acid compound. Given that gambogic acid has documented anti-cancer characteristics, Lin's invention opens the door for the development of new anti-tumor drugs, potentially impacting cancer treatment positively.

Career Highlights

Changjun Lin is associated with China Pharmaceutical University, where his research intertwines pharmaceutical chemistry and medicinal innovation. His expertise in the field has led him to develop impactful solutions that can contribute significant advancements in drug formulation and delivery.

Collaborations

Throughout his career, Lin has collaborated with esteemed colleagues, including Qidong You and Xiaojian Wang. These partnerships highlight the importance of teamwork in research and innovation, bringing together diverse expertise to push the boundaries of pharmaceutical development.

Conclusion

In summary, Changjun Lin stands out as a key figure in the realm of pharmaceutical chemistry. His patent reflects not only his innovative thinking but also his dedication to addressing health-related issues through science. As his career progresses, Lin's contributions are expected to shape the future of drug development and enhance therapeutic options available to patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…